568 related articles for article (PubMed ID: 31832109)
1. Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice.
Bubnov R; Babenko L; Lazarenko L; Kryvtsova M; Shcherbakov O; Zholobak N; Golubnitschaja O; Spivak M
EPMA J; 2019 Dec; 10(4):317-335. PubMed ID: 31832109
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of probiotic effects of
Bubnov RV; Babenko LP; Lazarenko LM; Mokrozub VV; Demchenko OA; Nechypurenko OV; Spivak MY
EPMA J; 2017 Dec; 8(4):357-376. PubMed ID: 29209439
[TBL] [Abstract][Full Text] [Related]
3. Specific properties of probiotic strains: relevance and benefits for the host.
Bubnov RV; Babenko LP; Lazarenko LM; Mokrozub VV; Spivak MY
EPMA J; 2018 Jun; 9(2):205-223. PubMed ID: 29896319
[TBL] [Abstract][Full Text] [Related]
4. Probiotic strains of lactobacilli and bifidobacteria alter pro- and anti-inflammatory cytokines production in rats with monosodium glutamate-induced obesity.
Falalyeyeva TM; Leschenko IV; Beregova TV; Lazarenko LM; Savchuk OM; Sichel LM; Tsyryuk OI; Vovk TB; Spivak MY
Fiziol Zh (1994); 2017; 63(1):17-25. PubMed ID: 29975824
[TBL] [Abstract][Full Text] [Related]
5. The role of beneficial bacteria wall elasticity in regulating innate immune response.
Мokrozub VV; Lazarenko LM; Sichel LM; Babenko LP; Lytvyn PM; Demchenko OM; Melnichenko YO; Boyko NV; Biavati B; DiGioia D; Bubnov RV; Spivak MY
EPMA J; 2015; 6(1):13. PubMed ID: 26110044
[TBL] [Abstract][Full Text] [Related]
6. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
Kobyliak N; Falalyeyeva T; Virchenko O; Mykhalchyshyn G; Bodnar P; Spivak M; Yankovsky D; Beregova T; Ostapchenko L
BMC Gastroenterol; 2016 Mar; 16():34. PubMed ID: 26976285
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Safety of Lactobacillus casei IMV B-7280 Probiotic Strain on a Mouse Model.
L M L; L P B; S G G; L O S; O M D; R V B; L M S; M Ya S
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1644-1657. PubMed ID: 33876388
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of immune response, microbiota, and blood markers after probiotic bacteria administration in obese mice induced by a high-fat diet.
Núñez IN; Galdeano CM; de LeBlanc Ade M; Perdigón G
Nutrition; 2014; 30(11-12):1423-32. PubMed ID: 25280423
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats.
Bomhof MR; Saha DC; Reid DT; Paul HA; Reimer RA
Obesity (Silver Spring); 2014 Mar; 22(3):763-71. PubMed ID: 24124012
[TBL] [Abstract][Full Text] [Related]
10. Maternal Administration of Probiotic or Prebiotic Prevents Male Adult Rat Offspring against Developmental Programming of Hypertension Induced by High Fructose Consumption in Pregnancy and Lactation.
Hsu CN; Lin YJ; Hou CY; Tain YL
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30181501
[TBL] [Abstract][Full Text] [Related]
11. The effect of Lacto- and Bifidobacteria in monoculture on the vaginal microflora in norm and in cases of intravaginal staphylococcosis.
Babenko LR; Lazarenko LM; Shynkarenko LM; Mokrozub VV; Pidgorskyi VS; Spivak MJ
Mikrobiol Z; 2013; 75(3):46-55. PubMed ID: 23866586
[TBL] [Abstract][Full Text] [Related]
12. Lactic Acid Bacteria Strains Differently Modulate Gut Microbiota and Metabolic and Immunological Parameters in High-Fat Diet-Fed Mice.
Fabersani E; Marquez A; Russo M; Ross R; Torres S; Fontana C; Puglisi E; Medina R; Gauffin-Cano P
Front Nutr; 2021; 8():718564. PubMed ID: 34568404
[No Abstract] [Full Text] [Related]
13. In vivo screening of multiple bacterial strains identifies Lactobacillus rhamnosus Lb102 and Bifidobacterium animalis ssp. lactis Bf141 as probiotics that improve metabolic disorders in a mouse model of obesity.
Le Barz M; Daniel N; Varin TV; Naimi S; Demers-Mathieu V; Pilon G; Audy J; Laurin É; Roy D; Urdaci MC; St-Gelais D; Fliss I; Marette A
FASEB J; 2019 Apr; 33(4):4921-4935. PubMed ID: 30596521
[TBL] [Abstract][Full Text] [Related]
14. Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity.
Sergeev IN; Aljutaily T; Walton G; Huarte E
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31952249
[TBL] [Abstract][Full Text] [Related]
15. Exopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient mice.
London LE; Kumar AH; Wall R; Casey PG; O'Sullivan O; Shanahan F; Hill C; Cotter PD; Fitzgerald GF; Ross RP; Caplice NM; Stanton C
J Nutr; 2014 Dec; 144(12):1956-62. PubMed ID: 25320181
[TBL] [Abstract][Full Text] [Related]
16. Hypertension Programmed by Perinatal High-Fat Diet: Effect of Maternal Gut Microbiota-Targeted Therapy.
Hsu CN; Hou CY; Chan JYH; Lee CT; Tain YL
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31810197
[TBL] [Abstract][Full Text] [Related]
17. Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition.
Kobyliak N; Falalyeyeva T; Beregova T; Spivak M
Endokrynol Pol; 2017; 68(6):659-667. PubMed ID: 29022648
[TBL] [Abstract][Full Text] [Related]
18. Gut Bifidobacterium responses to probiotic Lactobacillus casei Zhang administration vary between subjects from different geographic regions.
Zhao F; Bai X; Zhang J; Kwok LY; Shen L; Jin H; Sun T; Sun Z; Zhang H
Appl Microbiol Biotechnol; 2022 Apr; 106(7):2665-2675. PubMed ID: 35318524
[TBL] [Abstract][Full Text] [Related]
19. The effect of lacto- and bifidobacteria compositions on the vaginal microflora in cases of intravaginal staphylococcosis.
Babenko LP; Lazarenko LM; Shynkarenko LM; Mokrozub VV; Pidgorskyi VS; Spivak MJ
Mikrobiol Z; 2012; 74(5):116-25. PubMed ID: 23120992
[TBL] [Abstract][Full Text] [Related]
20. Effect of probiotic, prebiotic, and synbiotic on the gut microbiota of autistic children using an in vitro gut microbiome model.
Duque ALRF; Demarqui FM; Santoni MM; Zanelli CF; Adorno MAT; Milenkovic D; Mesa V; Sivieri K
Food Res Int; 2021 Nov; 149():110657. PubMed ID: 34600659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
